AESI Safety Reporting Materials

Developed during the COVID-19 vaccine rollout, these materials supported clear and consistent reporting of Adverse Events of Special Interest (AESI), specifically related to thrombosis with thrombocytopenia syndrome (TTS). The assets translated complex reporting procedures into accessible, step-by-step workflows tailored for clinical trial settings. Designed with real-time usability in mind, the posters helped ensure accurate data entry and protocol adherence on a global scale, underscoring the critical role of design in high-stakes medical communication.